NovaVive Inc. - Canine

NovaVive Inc. - Canine NovaVive offers a regulator-approved immunotherapy for canine mammary cancer in the USA and Canada. NovaVive Inc.

is an animal health immunobiology company with a regulator-approved canine cancer product available to veterinarians in CA and the US.

Every cancer patient presents a unique set of considerations, which is why veterinarians rely on individualized treatmen...
08/26/2026

Every cancer patient presents a unique set of considerations, which is why veterinarians rely on individualized treatment plans.

Immunocidin® is an immunotherapeutic available for the treatment of canine mammary tumors. By stimulating the innate immune response, it provides veterinarians with another treatment option.

Clinical evaluation in the licensing study found that 88% of dogs receiving Immunocidin® as a sole treatment remained tumor-free two years after treatment.

Discover more about Immunocidin® at NovaVive.ca/products.

Cancer treatment isn't one-size-fits-all, and veterinary medicine continues to provide clinicians with a growing range o...
08/20/2026

Cancer treatment isn't one-size-fits-all, and veterinary medicine continues to provide clinicians with a growing range of treatment options.

Immunocidin® is an immunotherapeutic treatment designed to stimulate the body's innate immune response to fight cancer. It provides veterinarians with another option to consider when developing treatment plans for eligible canine patients.

Explore the science behind Immunocidin® and download the product brochure at NovaVive.ca/products.

Every patient is different, which is why veterinarians appreciate having multiple tools available when developing treatm...
08/18/2026

Every patient is different, which is why veterinarians appreciate having multiple tools available when developing treatment plans.

NovaVive manufactures immunotherapeutic products designed to support veterinarians across equine, canine, and bovine medicine through innovative immune system science.

Learn more about our products and research at NovaVive.ca.

When a dog receives a mammary cancer diagnosis, every decision becomes an important one.Immunocidin® is an immunotherape...
08/14/2026

When a dog receives a mammary cancer diagnosis, every decision becomes an important one.

Immunocidin® is an immunotherapeutic product available to veterinarians for the treatment of canine mammary tumors and may be incorporated into a treatment plan, as determined by the attending veterinarian.

Every patient is unique, and treatment decisions should always be based on an individual dog's condition and overall health.

Learn more about Immunocidin® at NovaVive.ca/products.

In Loving Memory of Max 🐾Max was a 15-year-old American Pit Bull Terrier from Golden, Colorado who was diagnosed with tr...
08/04/2026

In Loving Memory of Max 🐾

Max was a 15-year-old American Pit Bull Terrier from Golden, Colorado who was diagnosed with transitional cell carcinoma (TCC) of the bladder in October 2020.

He passed away on June 16, 2026... 292 weeks after beginning Immunocidin® therapy.

"We never imagined we'd have almost six more years with him. We are thankful to NovaVive for providing the Immunocidin we believe gave us so much extra time together. We are heartbroken without him and forever grateful he was ours." – Max's family

Our heartfelt condolences go out to Max's family. Thank you for allowing us to be a small part of Max's journey. ❤️

Every case is unique. Learn more and read the full product brochure at NovaVive.ca/products.


Many mammary tumors are diagnosed in middle-aged or senior dogs, but treatment decisions involve much more than age alon...
07/25/2026

Many mammary tumors are diagnosed in middle-aged or senior dogs, but treatment decisions involve much more than age alone.

Veterinarians consider overall health, quality of life, concurrent medical conditions, and owner goals when developing an individualized care plan.
Immunocidin® offers veterinarians an immunotherapeutic option for the treatment of canine mammary tumors and may be incorporated into treatment plans according to label directions.

Read the product brochure at NovaVive.ca/products.

A mammary tumor diagnosis often leads to many questions and that's okay.Understanding the diagnosis, discussing availabl...
07/19/2026

A mammary tumor diagnosis often leads to many questions and that's okay.

Understanding the diagnosis, discussing available treatment options, and setting realistic expectations are all important parts of developing a care plan.

Immunocidin® is approved for the treatment of canine mammary tumors and provides veterinarians with an immunotherapeutic option that may be used as a sole treatment, before surgery, after surgery, or alongside chemotherapy.

The best treatment plan is one developed through open communication between pet owners and their veterinary team.

Explore complete product information at NovaVive.ca/products.

07/16/2026

Meet Ben. ❤️

Ben is a 7-year-old German Shepherd from New Brunswick, Canada, who was diagnosed with osteosarcoma in January 2025 after what first appeared to be a simple limp. Following his diagnosis, Ben underwent amputation, chemotherapy, and began treatment with Immunocidin® in February 2025 as part of a NovaVive pilot study.

Today, Ben has adapted remarkably well to life on three legs and continues to enjoy the things he loves most, long car rides, boat rides, family time, and playing with his German Shepherd companion, Blake.
For Ben's owner, his journey is especially meaningful.

"Ben is more than just a pet. He is my service dog, my constant companion, and one of the most important parts of my daily life. I truly believe he has saved my life more than once."

After receiving Ben's diagnosis, his family researched every available option before connecting with NovaVive. They are grateful to have participated in the pilot study and thankful for the care and support provided by Dr. Miriam Cervantes, the NovaVive research team, and everyone involved.

Thank you to Ben's family for allowing us to share his story.

Learn more about Immunocidin® and NovaVive's immunotherapeutic research at NovaVive.ca/products.

Hearing that a dog has been diagnosed with a mammary tumor can be overwhelming. Fortunately, today's veterinarians have ...
07/08/2026

Hearing that a dog has been diagnosed with a mammary tumor can be overwhelming. Fortunately, today's veterinarians have a variety of treatment options to consider based on each patient's individual needs.

Immunocidin® is an immunotherapeutic approved for the treatment of canine mammary tumors. It may be used as a sole treatment, prior to surgery for tumor debulking, after surgery, or in combination with chemotherapy.

Every patient is different, making communication between pet owners and veterinarians an important part of developing an individualized treatment plan.

Learn more about Immunocidin® at NovaVive.ca/products.


Q: Can Immunocidin® be used alongside surgery?A: Yes. Immunocidin® may be incorporated into treatment protocols before s...
06/30/2026

Q: Can Immunocidin® be used alongside surgery?

A: Yes. Immunocidin® may be incorporated into treatment protocols before surgery, after surgery, as a sole treatment, or alongside other therapies under veterinary supervision.

Treatment decisions should always be made in consultation with a veterinarian based on the individual patient's needs.

Learn more at NovaVive.ca/products.


Address

15 Dairy Avenue
Napanee, ON
K7R1M4

Website

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Canine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share